Alleviant Medical

Alleviant Medical Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $6.5M
Latest Deal Amount
  • Investors
  • 10

Alleviant Medical General Information

Description

Developer of medical devices intended for the treatment of congestive heart failures. The company's medical device leverages its proprietary technology to relieve pressure buildup in the left atrium of the heart that can possibly lead to organ failures, thereby allowing hospitals to provide symptomatic relief and appropriate treatments to its patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 7801 North Lamar Boulevard
  • Suite D-106
  • Austin, TX 78752
  • United States

Alleviant Medical Timeline

201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alleviant Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Early Stage VC 14-May-2020 $6.5M 000.00 Completed Startup
8. Early Stage VC (Series A) 01-Apr-2019 00.00 00.00 000.00 Completed Startup
7. Angel (individual) 30-Mar-2018 00.000 00.000 Completed Startup
6. Grant 01-Jan-2018 00000 Completed Startup
5. Accelerator/Incubator 26-Sep-2017 Completed Startup
4. Accelerator/Incubator 23-May-2017 Completed Startup
3. Grant 06-Apr-2017 000 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 01-Jan-2017 Completed Startup

Alleviant Medical Cap Table

To view Alleviant Medical‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000

Alleviant Medical Executive Team (5)

Name Title Board Seat Contact Info
Adam Berman Chief Executive Officer, President and Board Member
Albertien Greijdanus Co-Founder and Vice President of Finance and Administration
Avni Patel Co-Founder
Jacob Kriegel MD Co-Founder, Chief Medical Officer & Board Member

1 Former Executive

Alleviant Medical Board Members (8)

To view Alleviant Medical‘s full board member team, request access »
Name Representing Role Since
Adam Berman Alleviant Medical Chief Executive Officer, President and Board Member 000 0000
Ashok Gowda Self Board Member 000 0000
Chris Kaster Self Board Member 000 0000
Jacob Kriegel MD Alleviant Medical Co-Founder, Chief Medical Officer & Board Member 000 0000
Kirk Nielsen Self Board Member 000 0000

1 Former Board Member

Alleviant Medical Investors (10)

To view Alleviant Medical‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boston Scientific Corporation 401(k) Retirement Savings Plan Limited Partner Minority 000 0000 000000 0
Broadview Ventures Venture Capital Minority 000 0000 000000 0
S3 Ventures Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial